Clinical Trial Update: Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating paclitaxel with or without ramucirumab in patients with previously treated squamous-cell carcinoma of the esophagus has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Esophagus

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Ramucirumab (ramucirumab)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Squamous Cell Carcinoma of the Esophagus | Phase 2 | Status: COMPLETED